Profile banner
Joel S. Tabb

Joel S. Tabb

Biochemist and diagnostics entrepreneur focused on SERS-based assays

Ithaca, New York
theorg+1
Favicon imagegrantengine.com
Favicon imagelinkedin.com

Summary

Founder and diagnostics entrepreneur who built and led a SERS + aptamer diagnostics startup (Ionica Sciences) focused on improving direct detection assays for infectious diseases such as Lyme disease. fuzehub+1
Practicing inventor and author: holds patents and co-authored peer-reviewed research on biosensors, SERS assays, and cell-based sensing technologies. justia+1
Experienced research scientist with academic collaborations and roles at institutions including Cornell; contributed to translating lab research into startup development and commercialization efforts. cornell+1
SBIR and non-dilutive funding practitioner: has participated in SBIR-funded projects and now advises clients on securing non-dilutive funding as a Product Funding Executive. sbir+1

Work

Education

Projects

Writing

REAGENTS AND METHODS FOR DETECTING INFECTIOUS DISEASES (Patent, US 11300519)

April 1, 2022

Patent (granted) covering SERS-active reagents and methods for detecting analytes in biological samples to diagnose infectious diseases and other targets; inventors include Joel S. Tabb and Omar Green; assigned to Ionica Sciences.

Favicon imagepatents.justia.com

An antigen-targeting assay for Lyme disease: Combining aptamers and SERS to detect the OspA protein

January 1, 2022

Describes a diagnostic platform that uses DNA aptamers and surface-enhanced Raman scattering (SERS) to detect the Lyme-specific OspA protein in serum, reporting ~91% sensitivity and a very low limit of detection.

Favicon imagepubmed.ncbi.nlm.nih.gov

Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor

January 1, 2009

Research on optimizing cell lines and conditions for electric cell-substrate impedance sensing (ECIS)-based toxicity sensors to improve sensitivity and field portability; lists Agave BioSystems affiliation.

Favicon imagepubmed.ncbi.nlm.nih.gov

DEVELOPMENT OF A MAST CELL-BASED BIOSENSOR

January 1, 2007

Describes development of mast cell-based biosensors for rapid detection of antigens and pathogens using fluorescent assays and engineered chimeric proteins to enable detection of bacteria.

Favicon imagepmc.ncbi.nlm.nih.gov